20 (AIDX) Current Leases (2024 - 2026)

20 (AIDX) reported Current Leases of $189649.0 for Q1 2026, up 7.79% quarter-over-quarter from $175948.0 in Q4 2025.

20 (AIDX) Current Leases (2024 - 2026) Analysis & Trends

20 has reported Current Leases for 3 years, with the latest figure at $189649.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases changed N/A year-over-year to $189649.0; the trailing twelve-month figure through Mar 2026 stood at $189649.0 (changed N/A YoY), and the FY2025 full-year result was $175948.0, up 6.18% from the prior year.
  • Current Leases for Q1 2026 stood at $189649.0, up from $175948.0 in the prior quarter.
  • The five-year high for Current Leases was $189649.0 in Q1 2026, with the low at $165702.0 in Q4 2024.
  • Historically, Current Leases has averaged $177099.7 across 3 years, with a median of $175948.0 in 2025.
  • The largest YoY upside for Current Leases was 6.18% in 2025 against a maximum downside of 6.18% in 2025.
  • 20's Current Leases stood at $165702.0 in 2024, then increased by 6.18% to $175948.0 in 2025, then rose by 7.79% to $189649.0 in 2026.
  • The last three Current Leases figures came in at $189649.0 (Q1 2026), $175948.0 (Q4 2025), and $165702.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 35.80 Mn
10 20 - - 62,884.00 189,649.00

Historic Data

Download Data
DateValue
Mar 31, 2026 189,649.00
Dec 31, 2025 175,948.00
Dec 31, 2024 165,702.00